Redefining large-scale SU TFF for multi-modality biomanufacturing
Wednesday, May 27, 2026
Session 1: 10 a.m. CET | 2:30 p.m. IST | 5 p.m. HKT
Session 2: 8 a.m. PST | 11 a.m. EST | 5 p.m. CET
In today’s biomanufacturing landscape, downstream operations must meet demand for rising titers, increasing viscosity, and a growing range of modalities from monoclonal antibodies to viral vectors and nucleic acids. Traditional tangential flow filtration strategies can struggle to maintain flexibility, speed, and consistent performance.
In this webinar, we’ll explore how a next-generation large-scale single-use TFF platform is enabling more agile downstream processing. Learn how optimized hydrodynamics, low working volumes, and advanced automated control strategies help maintain stable operating conditions, improve recovery, and simplify complex UF/DF workflows, even at high concentrations.
Learn how fully single-use execution can dramatically reduce turnaround times by eliminating cleaning validation and enabling rapid batch-to-batch transitions, helping multiproduct facilities increase capacity and respond faster to changing pipeline needs.
What You Will Learn:
- Explore what makes single-use execution a major driver of productivity for multiproduct sites.
- Discover how multimodality operations benefit from flexible, reconfigurable systems.
- See why high titer and high viscosity processes require advanced downstream control.
- Learn why a closed, contamination-controlled workflow is essential for certain modalities.
